FIS reports $17.4B net loss, goodwill impairment; spins off Merchant Solutions as Worldpay

Fidelity National Information Services, Inc.

Net loss of $17.4B ($29.28 diluted EPS) includes $17.6B non-cash goodwill impairment on Merchant Solutions.
Q4 2022 adjusted EPS $1.71 (down 11% YoY); full-year adjusted EPS $6.65 (up 2% YoY).
FY2022 revenue $14.5B, +5% GAAP, +7% organic; Merchant volume $2.2T, +5%.
Plans tax-free spin-off of Merchant Solutions (as Worldpay) within 12 months; Charles Drucker to be CEO.
FY2023 guidance: revenue $14.2-14.45B, adjusted EPS $5.70-6.00; Q1 adj EPS $1.17-1.23.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Fidelity National Information Services, Inc. reported three months and year ended December 31, 2022 results: revenue approximately $3.7 billion, net income $(17.4) billion or $(29.28) per diluted share, EPS $(29.28) per diluted share. Guidance initiated.

Period: three months and year ended December 31, 2022
Revenue: approximately $3.7 billion
Net income: $(17.4) billion or $(29.28) per diluted share
EPS: $(29.28) per diluted share
Guidance: initiated
Result: reported results

Exact text from the filing

for FIS shareholders, clients and colleagues.” Fourth Quarter 2022 On a GAAP basis, consolidated revenue increased 1% as compared to the prior-year period to approximately $3.7 billion. Net earnings (loss) attributable to common stockholders were $(17.4) billion or $(29.28) per diluted share. The Company recorded a non-cash goodwill impairment charge of $17.6

View on SEC.gov

Browse all earnings releases →

Fidelity National Information Services, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-034197

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.